We are live on ! Find out more
PAVM icon

PAVmed
PAVM

97 hedge funds and large institutions have $134M invested in PAVmed in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more capital invested

Capital invested by funds: $80.7M → $134M (+$53.8M)

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

54% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $1.19M

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

7% more funds holding

Funds holding: 91 → 97 (+6)

0.01% more ownership

Funds ownership: 0.05% → 0.06% (+0.01%)

Holders
97
Holders Change
+6
Holders Change %
+6.59%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
33
Reduced
21
Closed
19
Calls
$1.83M
Puts
$1.19M
Net Calls
+$642K
Net Calls Change
+$718K

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$5.3M
2
EI
EAM Investors
California
+$4.18M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.01M
4
EGI
EAM Global Investors
California
+$1.97M
5
State Street
State Street
Massachusetts
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
-$2.33M
2
PGM
Parian Global Management
New York
-$1.94M
3
Millennium Management
Millennium Management
New York
-$1.71M
4
Marshall Wace
Marshall Wace
United Kingdom
-$806K
5
Creative Planning
Creative Planning
Kansas
-$702K
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
51
MetLife Investment Management
New Jersey
$183K +$151K +64 New
VOYA Investment Management
52
VOYA Investment Management
Georgia
$183K +$18.9K +8 +14%
Bank of America
53
Bank of America
North Carolina
$179K -$276K -117 -65%
JP Morgan Chase
54
JP Morgan Chase
New York
$178K +$23.6K +10 +19%
T. Rowe Price Associates
55
T. Rowe Price Associates
Maryland
$171K -$194K -82 -58%
MWM
56
Minot Wealth Management
Massachusetts
$168K +$158K +67 New
CIBC Private Wealth Group
57
CIBC Private Wealth Group
Georgia
$160K -$59.1K -25 -31%
Qube Research & Technologies (QRT)
58
Qube Research & Technologies (QRT)
United Kingdom
$146K +$120K +51 New
Barclays
59
Barclays
United Kingdom
$137K -$163K -69 -59%
MWM
60
Meridian Wealth Management
Kentucky
$137K +$16.5K +7 +18%
PAG
61
Private Advisor Group
New Jersey
$134K +$35.4K +15 +48%
GWS
62
Glassman Wealth Services
Virginia
$133K +$9.45K +4 +10%
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$132K +$109K +46 New
IGGA
64
Iron Gate Global Advisors
Utah
$129K +$106K +45 New
FAIM
65
Financial Advocates Investment Management
Washington
$126K – – –
Invesco
66
Invesco
Georgia
$123K -$89.8K -38 -47%
CAN
67
Cetera Advisor Networks
California
$120K – – –
ProShare Advisors
68
ProShare Advisors
Maryland
$119K +$9.45K +4 +11%
PCM
69
Pinz Capital Management
New York
$116K -$102K -43 -52%
CSS
70
Cubist Systematic Strategies
Connecticut
$113K +$14.2K +6 +18%
DSAM
71
Dock Street Asset Management
Florida
$96K – – –
WCM
72
Washburn Capital Management
Florida
$93K +$75.6K +32 New
AB
73
Amalgamated Bank
New York
$87K +$70.9K +30 New
Victory Capital Management
74
Victory Capital Management
Texas
$80K – – –
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$75K +$61.4K +26 New
1 2
3
4 5

PAVM Hedge Fund Activity: Q2 2021 in Review

97 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2021, worth a combined $134M — up 67% from $80.7M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PAVM positions and 19 closed out — a net gain of 7 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Nuveen, adding an estimated $5.3M. The largest seller was Marshall Wace North America, cutting an estimated $2.33M.

  • 97 institutional investors held PAVmed (PAVM) as of Q2 2021, up from 91 in Q1 2021.
  • Funds reported $134M of PAVmed stock for Q2 2021, up 67% quarter-over-quarter.
  • 26 funds opened new PAVmed positions in Q2 2021 and 19 closed out, a net change of +7 holders.
  • The largest PAVmed buyer in Q2 2021 was Nuveen, an estimated $5.3M added.
  • The largest PAVmed seller in Q2 2021 was Marshall Wace North America, an estimated $2.33M sold.

Based on aggregated 13F filings for Q2 2021.